Dr. Ke-Qin Hu is the Director of Hepatology Services and Professor of Medicine at the University of California, Irvine School of Medicine. Dr. Hu received his medical education and training in Tongji Medical University, China. After his residency at Huntington Memorial Hospital, Pasadena, he completed a fellowship in Hepatology at the University of Southern California Liver Unit. Dr. Hu was awarded with the FAASLD designation and being a part of the inaugural class of AASLD Fellows in 2014.
Dr. Hu emphasizes bridging research advances to bedside patient care. Besides active involvement in clinical trials of hepatitis B and C treatment, his clinical research also focuses on natural history and outcomes of liver diseases and health care disparity. His basic research has focused on molecular virology and diagnosis of hepatitis B and C virus infection and chemoprevention of liver cancer. Dr. Hu has co-authored more than 100 research papers, book chapters, and review articles.
Dr. Hu is dedicated to community outreach and services, public health education, and reduction of health care disparity in Asian Americans. He is the advisory board member for several local and regional health promotion organizations. Dr. Hu has served Medical Advisory Board of the American Liver Foundation, Los Angeles and Orange County Chapter since 2003. He has also been awarded as an Orange County Physician of Excellence for the past years.